Form 8-K - Current report:
SEC Accession No. 0000950170-25-102419
Filing Date
2025-08-05
Accepted
2025-08-05 08:05:27
Documents
11
Period of Report
2025-08-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20250805.htm   iXBRL 8-K 50368
2 EX-99.1 meip-ex99_1.htm EX-99.1 16258
  Complete submission text file 0000950170-25-102419.txt   177074

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20250805.xsd EX-101.SCH 24867
13 EXTRACTED XBRL INSTANCE DOCUMENT meip-20250805_htm.xml XML 4705
Mailing Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 251182889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)